| Name | Title | Contact Details |
|---|
Vicus Therapeutics is a Morristown, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
North Canton Medical Foundation was founded in 1972 by a group of physicians who envisioned a non-profit physician group practice as a unique mechanism to bring high quality medical care to the community. Since 1972, North Canton Medical Foundation has
Petvisor is a company that delivers a suite of mobile-enabled technologies to pet care professionals, helping them care for pet families. They provide tools to engage customers, streamline operations, and grow businesses in the veterinary health and pe...
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
AFYA Inc is a Laurel, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.